LC

Lishen Capital

Asia, Guangdong, China, Shenzhen

Description

Lishen Capital

Investor Profile

Lishen Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Genetics, Medical.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Genetics
  • Medical
  • Pharmaceutical
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lishen Capital frequently co-invest with?

ASBV
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
DHVC
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Lishen Capital?

Aegicare

Palo Alto, California, United States

Aegicare is an artificial intelligence platform empowering precision medicine.

Artificial Intelligence (AI)GeneticsMedicalPharmaceuticalPrecision Medicine
SeedMar 2, 2018
Amount Raised: $3,800,000